Truqap can be a kinase inhibitor that works by blocking pathways that assist the most cancers cells survive and grow, so reduces most cancers progress. Truqap is from a class of medicines identified as an AKT inhibitor. Truqap obtained FDA approval on November seventeen, 2023, immediately after cons